All Stories

  1. Corrigendum to ‘Cancer chemotherapy and beyond: Current status, drug candidates, associated risks and progress in targeted therapeutics’ [Genes & Diseases 10 (2023) 1367–1401]

    Article • Genes & Diseases, July 2024, Tsinghua University Press

    José Manuel Perez de la Lastra

  2. Cancer chemotherapy and beyond: Current status, drug candidates, associated risks and progress in targeted therapeutics

    Article • Genes & Diseases, July 2023, Tsinghua University Press

    Amarnath Mishra, José Manuel Perez de la Lastra

  3. Betelvine ( Piper betle L.): A comprehensive insight into its ethnopharmacology, phytochemistry, and pharmacological, biomedical and therapeutic attributes

    Article • Journal of Cellular and Molecular Medicine, May 2022, Wiley

    José Manuel Perez de la Lastra, Dr Tulika Mishra, Ananya Bar

  4. Recent Advances in the Development of Anti-Infective Prophylactic and/or Therapeutic Agents Based on Toll-Like Receptor (TLRs)

    Article • Recent Patents on Anti-Infective Drug Discovery, September 2014, Bentham Science Publishers

    José Manuel Perez de la Lastra